Pharmacokinetic properties and indications for modern vasodilators. 1. Pharmacodynamic properties of vasodilators
Langnickel, R.; Bluth, R.
Zeitschrift für Arztliche Fortbildung 79(19): 821-825
1985
ISSN/ISBN: 0044-2178 PMID: 2866637 Document Number: 245718
Document emailed within 1 workday
Related Documents
Adam, D.; Heinzl, S. 1989: Oral penicillins. Pharmacodynamic and pharmacokinetic properties Medizinische Monatsschrift für Pharmazeuten 12(4): 117-122Bergogne-Bérézin, E. 1997: Fluoroquinolones. Pharmacokinetic properties and new pharmacodynamic concepts Presse Medicale 26(12): 577-582
Muir, W.W.; Sams, R.A.; Huffman, R.H.; Noonan, J.S. 1982: Pharmacodynamic and pharmacokinetic properties of diazepam in horses American Journal of Veterinary Research 43(10): 1756-1762
Brogden, R.N.; Buckley, M.M.; Ward, A. 1990: Buserelin. a review of its pharmacodynamic and pharmacokinetic properties, and clinical profile Drugs 39(3): 399-437
Weidinger, G. 1995: Pharmacokinetic and pharmacodynamic properties and therapeutic use of bunazosin in hypertension. A review Arzneimittel-Forschung 45(11): 1166-1171
Palmer, G.C.; Murray, R.J.; Cramer, C.L.; Stagnitto, M.L.; Knowles, M.K.; Freedman, L.R.; Eismann, M.S.; Mahmood, N.; Balestra, M.; Borrelli, A.R.; Hudzik, T.J.; McCarthy, D.J. 1999: S]-AR-R 15896AR-A novel anticonvulsant: acute safety, pharmacokinetic and pharmacodynamic properties Journal of Pharmacology and Experimental Therapeutics 288(1): 121-132
Orzechowska-Juzwenko, K. 1998: Optimizing pharmacotherapeutic aspects of pharmacokinetic and pharmacodynamic drug properties in the elderly Przeglad Lekarski 55(11): 607-610
Breithaupt-Grögler, K.; Malerczyk, C.; Belz, G.G.; Butzer, R.; Herrmann, V.; Stass, H.; Wensing, G. 1997: Pharmacodynamic and pharmacokinetic properties of an angiotensin Ii receptor antagonist--characterization by use of Schild regression technique in man International Journal of Clinical Pharmacology and Therapeutics 35(10): 434-441
Zsotér, T.T. 1983: Vasodilators Canadian Medical Association Journal 129(5): 424-428; 432
Bertrand, M.E.; Lablanche, J.M.; Fourrier, J.L. 1988: Vasodilators for intracoronary use Presse Medicale 17(20): 1010
Macri, R.; Redaelli, S. 1977: Vasodilators in VSDs Circulation 56(2): 329-330
Lowenthal, D.T. 1979: Clinical pharmacology of vasodilators New York State Journal of Medicine 79(1): 66-69
Raso, A.M.; Levis, P.; Sottimano, C. 1982: Vasodilators in vascular surgery Minerva Cardioangiologica 30(1-2): 15-20
Langlois, S.; Ogilvie, R.I. 1981: Vasodilators. 1- Main components L'Union Medicale du Canada 110(9): 786-789
Ladero Quesada, J.M. 1994: Vasodilators in portal hypertension Anales de Medicina Interna 11(4): 159-161
Forbes, L.S. 1972: Pharmacodynamic actions of diethylcarbamazine in the dog with particular reference to nicotine-like properties Southeast Asian Journal of Tropical Medicine and Public Health 3(1): 93-98
Morpurgo, M. 1990: Vasodilators in "primary" pulmonary hypertension? Giornale Italiano di Cardiologia 20(2): 123-125
Albillos, A.; Iborra, J. 1995: Vasodilators and renal function in cirrhosis Gastroenterologia y Hepatologia 18(9): 488-492
Slany, J. 1987: Do vasodilators help in chronic heart failure? Wiener Klinische Wochenschrift 99(5): 139-144
Malamov, E. 1980: Use of vasodilators in treating cardiac insufficiency Vutreshni Bolesti 19(5): 10-15